Aspen Aerogels (ASPN) Misses Q2 EPS by 6c

Aspen Aerogels (NYSE: ASPN) reported Q2 EPS of ($0.29), $0.06 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $21.7 million versus the consensus estimate of $25.45 million.

GUIDANCE:

Aspen Aerogels sees FY2018 EPS of ($0.87)-($0.95), versus the consensus of ($0.83). Aspen Aerogels sees FY2018 revenue of $102-112 million, versus the consensus of $111.46 million.

For earnings history and earnings-related data on Aspen Aerogels (ASPN) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• BMO Capital Reiterates Market Perform Rating on Axalta Coating Systems (AXTA)
• Morgan Stanley Upgrades Coal India Ltd (COAL:IN) to Overweight